EBGLYSS vs PROGRAF

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. EBGLYSS and PROGRAF are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	EBGLYSS	PROGRAF
Rating	New	72/100
Pharmacy pays	—	$0.65 /g
Type	RX	RX
Active ingredient	LEBRIKIZUMAB-LBKZ	TACROLIMUS
Manufacturer	Eli Lilly and Co	Astellas
Dosage forms	Injectable	Capsule, Powder, Injectable
Drug class	—	Calcineurin Inhibitor Immunosuppressant
Boxed warning	None	Boxed warning
Treats	Atopic Dermatitis	Atopic Dermatitis, Graft Vs Host Disease

ebglyss prograf

Rating

New

72/100

Pharmacy pays

—

$0.65 /g

Type

Active ingredient

LEBRIKIZUMAB-LBKZ

TACROLIMUS

Manufacturer

Eli Lilly and Co

Astellas

Dosage forms

Injectable

Capsule, Powder, Injectable

Drug class

—

Calcineurin Inhibitor Immunosuppressant

Boxed warning

None

Boxed warning

Treats

Atopic Dermatitis

Atopic Dermatitis, Graft Vs Host Disease

Frequently asked questions

What is the difference between Ebglyss and Prograf?

Ebglyss contains Lebrikizumab-Lbkz, while Prograf contains Tacrolimus — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.